Toronto, Canada – November 2025
East Optical is proud to announce the publication of two-year clinical data validating the long-term effectiveness of MyoPro® lenses in slowing myopia progression in children. These results, published in Investigative Ophthalmology & Visual Science (IOVS) and indexed on PubMed, demonstrate that MyoPro® continues to provide consistent, measurable outcomes after 24 months of wear.
Long-Term Results That Inspire Confidence
The two-year study, conducted at Wenzhou Medical University, builds on previously reported one-year results and confirms MyoPro®’s sustained effectiveness in controlling axial elongation — the key factor in myopia progression.
Children fitted with MyoPro® lenses showed:
– 67% slower myopia progression compared with single-vision lenses
– Up to 81.2% reduction in myopia progression in children aged 10–12
– 50% less axial elongation after two years
Importantly, children maintained excellent visual performance and comfort, with no adaptation issues reported during the study period.
About the Study
• Duration: 24 months
• Design: Double-blind, randomized clinical trial
• Institution: Wenzhou Medical University, China
• Participants: Children aged 8–13 years
This independent, peer-reviewed study strengthens MyoPro®’s position as a clinically proven, non-invasive solution for managing childhood myopia.
Read the full research here:
Why MyoPro Matters for Eye Care Professionals
For eye care professionals, these results provide the clinical confidence needed to recommend MyoPro® lenses as part of a comprehensive myopia management strategy.
“These new findings confirm that MyoPro® continues to deliver measurable and lasting benefits for children with myopia,” said Olive Su, East Optical General Manager. “We remain committed to supporting independent practices with scientifically proven technology that’s shaping the future of vision care.”
About MyoPro®
MyoPro® lenses feature 540 hexagonal micro-lenslets seamlessly integrated on the front surface, surrounding a small central clear zone. This innovative optical design creates a controlled defocus signal in front of the retina, effectively reducing axial elongation and slowing myopia progression over time.
Learn more at www.myopro.ca
